: Sanofi COVID-19 vaccine to cost below €10 and drug ingredients IPO planned within months, its France chief says
Sanofi stock rose on Monday, as a senior executive said its drugs ingredients IPO was planned for the coming months.
Sanofi stock rose on Monday, as a senior executive said its drugs ingredients IPO was planned for the coming months.